Close
Close

Pfizer - Non Small Cell Lung Cancer Harboring Molecular Alterations

Partner

Not provided

Rare Disease

Non Small Cell Lung Cancer Harboring Molecular Alterations

Sponsor

Pfizer

Access Program Information

This expanded access study has being designed following a demand from the FDA, given the increase in the number of request for single patient INDs for lorlatinib

Contact

Contact: Pfizer CT.gov Call Center (1-800-718-1021)

Locations
  • United States
  • Sedona, Arizona, United States

Free Newsletter